Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Comoglio

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
International Journal of Cancer|July 27, 1999
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC familyM Olivero, G Valente, A Bardelli, et al.
Oncogene|April 18, 1996
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomasR Ferracini, M Olivero, M F Di Renzo, et al.
Oncogene|July 22, 1998
Overexpression of the RON gene in human breast carcinomaP Maggiora, S Marchio, M C Stella, et al.
The EMBO Journal|February 3, 1997
Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytesL Amicone, F M Spagnoli, G Späth, et al.
Oncogene|May 8, 2012
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancerS Gastaldi, F Sassi, P Accornero, et al.
Cell|October 16, 1999
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebratesL Tamagnone, S Artigiani, H Chen, et al.
British Journal of Cancer|December 1, 1996
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomasM Olivero, M Rizzo, R Madeddu, et al.
Oncogene|August 16, 2016
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohortM Apicella, C Migliore, T Capelôa, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
International Journal of Cancer|July 27, 1999
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC familyM Olivero, G Valente, A Bardelli, et al.
Oncogene|April 18, 1996
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomasR Ferracini, M Olivero, M F Di Renzo, et al.
Oncogene|July 22, 1998
Overexpression of the RON gene in human breast carcinomaP Maggiora, S Marchio, M C Stella, et al.
The EMBO Journal|February 3, 1997
Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytesL Amicone, F M Spagnoli, G Späth, et al.
Oncogene|May 8, 2012
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancerS Gastaldi, F Sassi, P Accornero, et al.
Cell|October 16, 1999
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebratesL Tamagnone, S Artigiani, H Chen, et al.
British Journal of Cancer|December 1, 1996
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomasM Olivero, M Rizzo, R Madeddu, et al.
Oncogene|August 16, 2016
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohortM Apicella, C Migliore, T Capelôa, et al.
Pageof 23